Chun Yin William Leung, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Miller Fisher Syndrome | 1 | 2021 | 7 | 0.780 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2021 | 127 | 0.680 |
Why?
|
| Reperfusion | 1 | 2020 | 271 | 0.670 |
Why?
|
| Hyperphagia | 1 | 2019 | 139 | 0.610 |
Why?
|
| Encephalitis | 1 | 2021 | 438 | 0.580 |
Why?
|
| Patient Admission | 1 | 2020 | 1365 | 0.420 |
Why?
|
| Hong Kong | 5 | 2023 | 163 | 0.370 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 1921 | 0.340 |
Why?
|
| Seizures | 3 | 2023 | 2954 | 0.330 |
Why?
|
| Colonoscopy | 1 | 2016 | 1396 | 0.290 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 3194 | 0.270 |
Why?
|
| Cerebral Hemorrhage | 4 | 2023 | 2641 | 0.230 |
Why?
|
| Emergency Service, Hospital | 3 | 2020 | 7871 | 0.200 |
Why?
|
| Methemoglobinemia | 1 | 2021 | 44 | 0.190 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 3196 | 0.190 |
Why?
|
| Gangliosides | 1 | 2021 | 132 | 0.180 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8601 | 0.170 |
Why?
|
| Emergency Medical Technicians | 1 | 2020 | 119 | 0.170 |
Why?
|
| Anticonvulsants | 2 | 2020 | 1906 | 0.170 |
Why?
|
| Stroke | 4 | 2023 | 9712 | 0.170 |
Why?
|
| Megestrol | 1 | 2019 | 9 | 0.170 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 335 | 0.150 |
Why?
|
| Off-Label Use | 1 | 2019 | 185 | 0.140 |
Why?
|
| Pandemics | 3 | 2020 | 8645 | 0.130 |
Why?
|
| Epilepsy | 2 | 2023 | 3288 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 6925 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1185 | 0.130 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 151 | 0.120 |
Why?
|
| Occult Blood | 1 | 2016 | 197 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 874 | 0.120 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2016 | 170 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2021 | 868 | 0.110 |
Why?
|
| Pyridones | 1 | 2019 | 808 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 2379 | 0.100 |
Why?
|
| Blood Pressure | 3 | 2022 | 8472 | 0.100 |
Why?
|
| Hypertension | 2 | 2022 | 8529 | 0.090 |
Why?
|
| Myocardial Infarction | 2 | 2022 | 11459 | 0.090 |
Why?
|
| Benzodiazepines | 1 | 2017 | 1132 | 0.090 |
Why?
|
| Caregivers | 1 | 2023 | 2241 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1520 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 58894 | 0.080 |
Why?
|
| Retrospective Studies | 8 | 2023 | 80566 | 0.070 |
Why?
|
| Incidence | 2 | 2021 | 21337 | 0.070 |
Why?
|
| Humans | 17 | 2023 | 760617 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2021 | 3400 | 0.060 |
Why?
|
| Male | 9 | 2021 | 360358 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2022 | 54360 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11069 | 0.050 |
Why?
|
| Globus Pallidus | 1 | 2023 | 250 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 10704 | 0.040 |
Why?
|
| Depression | 1 | 2020 | 8132 | 0.040 |
Why?
|
| Clonazepam | 1 | 2020 | 135 | 0.040 |
Why?
|
| Hospitals, Special | 1 | 2020 | 91 | 0.040 |
Why?
|
| Female | 8 | 2021 | 392148 | 0.040 |
Why?
|
| Aged | 6 | 2021 | 169042 | 0.040 |
Why?
|
| Recurrence | 2 | 2021 | 8426 | 0.040 |
Why?
|
| Hematoma | 1 | 2023 | 762 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2020 | 500 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2020 | 443 | 0.040 |
Why?
|
| Middle Aged | 6 | 2021 | 220584 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2020 | 9643 | 0.030 |
Why?
|
| Risk Factors | 5 | 2022 | 74115 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2021 | 1281 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2020 | 702 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 1431 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 1163 | 0.030 |
Why?
|
| Nitriles | 1 | 2019 | 971 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2019 | 2048 | 0.030 |
Why?
|
| Adult | 3 | 2020 | 220969 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 2055 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22148 | 0.020 |
Why?
|
| China | 1 | 2017 | 2374 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 6520 | 0.020 |
Why?
|
| Time Factors | 2 | 2021 | 39913 | 0.020 |
Why?
|
| Acute Disease | 1 | 2020 | 7237 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12719 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10548 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10754 | 0.010 |
Why?
|
| Dementia | 1 | 2017 | 2680 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5332 | 0.010 |
Why?
|
| Child | 2 | 2020 | 80079 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 88234 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2020 | 26180 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23972 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 41457 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39063 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36152 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 42188 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59179 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64568 | 0.010 |
Why?
|